NCT02306772View on ClinicalTrials.gov

TP0501 - Pharmaco-Scintigraphic-Study

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions
Ulcerative Colitis
Interventions
DRUG

TP05 Coating A

One radio-labelled tablet given to subjects

DRUG

TP05 Coating B

One radio-labelled tablet given to subjects

All Listed Sponsors
lead

Tillotts Pharma AG

INDUSTRY

NCT02306772 - TP0501 - Pharmaco-Scintigraphic-Study | Biotech Hunter | Biotech Hunter